Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome.

Floris A, Piga M, Pinna S, Angioni MM, Congia M, Mascia P, Chessa E, Cangemi I, Mathieu A, Cauli A.

Open Access Rheumatol. 2019 Oct 8;11:219-227. doi: 10.2147/OARRR.S225168. eCollection 2019.

2.

Treatment target in newly diagnosed Systemic Lupus Erythematosus.

Floris A, Piga M, Perra D, Chessa E, Congia M, Mathieu A, Cauli A.

Arthritis Care Res (Hoboken). 2019 Oct 10. doi: 10.1002/acr.24086. [Epub ahead of print]

PMID:
31600023
3.

Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC).

Lliso-Ribera G, Humby F, Lewis M, Nerviani A, Mauro D, Rivellese F, Kelly S, Hands R, Bene F, Ramamoorthi N, Hackney JA, Cauli A, Choy EH, Filer A, Taylor PC, McInnes I, Townsend MJ, Pitzalis C.

Ann Rheum Dis. 2019 Oct 2. pii: annrheumdis-2019-215751. doi: 10.1136/annrheumdis-2019-215751. [Epub ahead of print]

4.

Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes.

Lewis MJ, Barnes MR, Blighe K, Goldmann K, Rana S, Hackney JA, Ramamoorthi N, John CR, Watson DS, Kummerfeld SK, Hands R, Riahi S, Rocher-Ros V, Rivellese F, Humby F, Kelly S, Bombardieri M, Ng N, DiCicco M, van der Heijde D, Landewé R, van der Helm-van Mil A, Cauli A, McInnes IB, Buckley CD, Choy E, Taylor PC, Townsend MJ, Pitzalis C.

Cell Rep. 2019 Aug 27;28(9):2455-2470.e5. doi: 10.1016/j.celrep.2019.07.091.

5.

Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation.

Tedeschi V, Alba J, Paladini F, Paroli M, Cauli A, Mathieu A, Sorrentino R, D'Abramo M, Fiorillo MT.

Cells. 2019 Jun 11;8(6). pii: E572. doi: 10.3390/cells8060572.

6.

The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia.

Paladini F, Fiorillo MT, Tedeschi V, D'Otolo V, Piga M, Cauli A, Mathieu A, Sorrentino R.

Rheumatology (Oxford). 2019 Jun 17. pii: kez212. doi: 10.1093/rheumatology/kez212. [Epub ahead of print]

PMID:
31209470
7.

Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.

Humby F, Lewis M, Ramamoorthi N, Hackney JA, Barnes MR, Bombardieri M, Setiadi AF, Kelly S, Bene F, DiCicco M, Riahi S, Rocher V, Ng N, Lazarou I, Hands R, van der Heijde D, Landewé RBM, van der Helm-van Mil A, Cauli A, McInnes I, Buckley CD, Choy EH, Taylor PC, Townsend MJ, Pitzalis C.

Ann Rheum Dis. 2019 Jun;78(6):761-772. doi: 10.1136/annrheumdis-2018-214539. Epub 2019 Mar 16.

8.

Ankylosing Spondylitis: A Trade Off of HLA-B27, ERAP, and Pathogen Interconnections? Focus on Sardinia.

Paladini F, Fiorillo MT, Tedeschi V, Cauli A, Mathieu A, Sorrentino R.

Front Immunol. 2019 Jan 25;10:35. doi: 10.3389/fimmu.2019.00035. eCollection 2019.

9.

Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus.

Todoerti M, Favalli EG, Iannone F, Olivieri I, Benucci M, Cauli A, Mathieu A, Santo L, Minisola G, Lapadula G, Bucci R, Gremese E, Caporali R.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii42-vii53. doi: 10.1093/rheumatology/key195. Review.

PMID:
30289539
10.

AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population.

Angioni MM, Piga M, Paladini F, Lai S, Erre GL, Floris A, Cauli A, Fiorillo MT, Passiu G, Carcassi C, Sorrentino R, Mathieu A.

PLoS One. 2018 Sep 25;13(9):e0204250. doi: 10.1371/journal.pone.0204250. eCollection 2018.

11.

Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis.

Cauli A, Dessole G, Piga M, Angioni MM, Pinna S, Floris A, Congia M, Mascia E, Paladini F, Tedeschi V, Sorrentino R, Fiorillo MT, Mathieu A.

RMD Open. 2018 Jul 13;4(2):e000597. doi: 10.1136/rmdopen-2017-000597. eCollection 2018.

12.

An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes.

Paladini F, Fiorillo MT, Vitulano C, Tedeschi V, Piga M, Cauli A, Mathieu A, Sorrentino R.

Sci Rep. 2018 Jul 10;8(1):10398. doi: 10.1038/s41598-018-28799-8.

13.

Polymyalgia rheumatica: an autoinflammatory disorder?

Floris A, Piga M, Cauli A, Salvarani C, Mathieu A.

RMD Open. 2018 Jun 4;4(1):e000694. doi: 10.1136/rmdopen-2018-000694. eCollection 2018. No abstract available.

14.

Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study.

Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Scarpa R, Marchesoni A, Taylor WJ, Salvarani C, Kalden J, Lubrano E, Carneiro S, Piga M, Floris A, Desiati F, Flynn JA, D'Angelo S, van Kuijk AWR, Catanoso MG, Caso F, Contu P, Ujfalussy I, Helliwell PS, Mease PJ; GRAPPA 3PPsA Study Group.

J Rheumatol. 2018 Aug;45(9):1256-1262. doi: 10.3899/jrheum.171183. Epub 2018 Jun 15.

PMID:
29907666
15.

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus.

Floris A, Piga M, Mangoni AA, Bortoluzzi A, Erre GL, Cauli A.

Mediators Inflamm. 2018 Feb 18;2018:3424136. doi: 10.1155/2018/3424136. eCollection 2018. Review.

16.

Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study.

Erre GL, Piga M, Fedele AL, Mura S, Piras A, Cadoni ML, Cangemi I, Dessi M, Di Sante G, Tolusso B, Gremese E, Cauli A, Mangoni AA, Saba PS, Carru C, Ferraccioli G, Mathieu A, Passiu G.

Mediators Inflamm. 2018 Feb 1;2018:6548715. doi: 10.1155/2018/6548715. eCollection 2018.

17.

Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series.

Chessa E, Piga M, Floris A, Mathieu A, Cauli A.

Reumatismo. 2017 Dec 21;69(4):175-183. doi: 10.4081/reumatismo.2017.1007. Review.

18.

Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology.

Marchesoni A, Olivieri I, Salvarani C, Pipitone N, D'Angelo S, Mathieu A, Cauli A, Punzi L, Ramonda R, Scarpa R, Maccarone M, Lubrano E.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):991-1010. Epub 2017 Nov 28.

PMID:
29185959
19.

Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.

Piga M, Floris A, Cappellazzo G, Chessa E, Congia M, Mathieu A, Cauli A.

Arthritis Res Ther. 2017 Nov 10;19(1):247. doi: 10.1186/s13075-017-1451-5.

20.

Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care.

Chessa E, Piga M, Floris A, Mathieu A, Cauli A.

Open Access Rheumatol. 2017 Sep 11;9:167-170. doi: 10.2147/OARRR.S143768. eCollection 2017.

21.

Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease.

Piga M, Floris A, Mathieu A, Cauli A.

Rheumatology (Oxford). 2017 Nov 1;56(11):2038-2039. doi: 10.1093/rheumatology/kex313. No abstract available.

PMID:
28968887
22.

Re: "Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination".

Piga M, Gabba A, Mathieu A, Cauli A.

Ultrasound Med Biol. 2017 Dec;43(12):2959. doi: 10.1016/j.ultrasmedbio.2017.08.002. Epub 2017 Sep 4. No abstract available.

PMID:
28882519
23.

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.

Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG.

Autoimmun Rev. 2017 Sep;16(9):911-924. doi: 10.1016/j.autrev.2017.07.012. Epub 2017 Jul 11. Review.

PMID:
28705780
24.

Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus.

Piga M, Congia M, Gabba A, Figus F, Floris A, Mathieu A, Cauli A.

Lupus. 2018 Feb;27(2):190-198. doi: 10.1177/0961203317716319. Epub 2017 Jun 15.

PMID:
28618891
25.

Can Synovial Pathobiology Integrate with Current Clinical and Imaging Prediction Models to Achieve Personalized Health Care in Rheumatoid Arthritis?

Humby FC, Al Balushi F, Lliso G, Cauli A, Pitzalis C.

Front Med (Lausanne). 2017 May 3;4:41. doi: 10.3389/fmed.2017.00041. eCollection 2017. Review.

26.

Proceedings of the GRAPPA 2016 Retreat.

Jadon DR, Gladman DD, Mease PJ, FitzGerald O, Chandran V, Goel N, Rosen CF, Maksymowych WP, Ritchlin CT, Ogdie A, Coates LC, Cauli A, Soriano ER, Husni ME, Campbell W, Azevedo VF, Callis Duffin K, Armstrong AW, Gottlieb AB, Kavanaugh A, Garg A, Helliwell PS.

J Rheumatol. 2017 May;44(5):668-673. doi: 10.3899/jrheum.170141.

PMID:
28461522
27.

Telemedicine for patients with rheumatic diseases: Systematic review and proposal for research agenda.

Piga M, Cangemi I, Mathieu A, Cauli A.

Semin Arthritis Rheum. 2017 Aug;47(1):121-128. doi: 10.1016/j.semarthrit.2017.03.014. Epub 2017 Mar 22. Review.

PMID:
28420491
28.

Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis.

Piga M, Chessa E, Peltz MT, Floris A, Mathieu A, Cauli A.

Autoimmun Rev. 2017 Mar;16(3):244-252. doi: 10.1016/j.autrev.2017.01.011. Epub 2017 Jan 31.

PMID:
28159705
29.

Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: comparison with computed tomography.

Piga M, Saba L, Gabba A, Congia M, Balestrieri A, Mathieu A, Cauli A.

Arthritis Res Ther. 2016 Oct 4;18(1):222.

30.

Circulating CD8+CD28null T Cytotoxic Cells in Polymyositis-A Possible Biomarker? Comment on the Article by Pandya et al.

Iannone F, Lopalco G, Cauli A, Cantarini L.

Arthritis Rheumatol. 2017 Jan;69(1):243. doi: 10.1002/art.39942. No abstract available.

31.

The Ankylosing Spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients.

Tedeschi V, Vitulano C, Cauli A, Paladini F, Piga M, Mathieu A, Sorrentino R, Fiorillo MT.

Mol Med. 2016 Sep;22:215-223. doi: 10.2119/molmed.2016.00031. Epub 2016 May 18.

32.

Predictors of musculoskeletal flares and Jaccoud׳s arthropathy in patients with systemic lupus erythematosus: A 5-year prospective study.

Piga M, Gabba A, Congia M, Figus F, Cauli A, Mathieu A.

Semin Arthritis Rheum. 2016 Oct;46(2):217-224. doi: 10.1016/j.semarthrit.2016.04.005. Epub 2016 Apr 28.

PMID:
27238877
33.

PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels.

Piga M, Pesella F, Corraine ML, Floris A, Cauli A, Mathieu A.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):723-4. Epub 2016 Mar 10. No abstract available.

PMID:
26968020
34.

Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review.

Floris A, Piga M, Cauli A, Mathieu A.

Autoimmun Rev. 2016 Jul;15(7):656-63. doi: 10.1016/j.autrev.2016.02.019. Epub 2016 Feb 26. Review.

PMID:
26921641
35.

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.

Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O'Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, Tuong W, Ritchlin CT.

Arthritis Rheumatol. 2016 May;68(5):1060-71. doi: 10.1002/art.39573. Epub 2016 Mar 23.

36.

Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study.

Olivieri I, Cortesi PA, de Portu S, Salvarani C, Cauli A, Lubrano E, Spadaro A, Cantini F, Ciampichini R, Cutro MS, Mathieu A, Matucci-Cerinic M, Punzi L, Scarpa R, Mantovani LG; PACE Working Group.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):68-75. Epub 2015 Dec 3.

PMID:
26633622
37.

The Difficult Task of Assessing Psoriatic Arthritis.

Cauli A, Piga M.

J Rheumatol. 2015 Dec;42(12):2219-20. doi: 10.3899/jrheum.151209. No abstract available.

PMID:
26628707
38.

New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol.

Cauli A, Piga M, Lubrano E, Marchesoni A, Floris A, Mathieu A.

J Rheumatol Suppl. 2015 Nov;93:70-2. doi: 10.3899/jrheum.150641. Review.

PMID:
26523062
39.

Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs.

Marchesoni A, Lubrano E, Cauli A, Ricci M, Manara M.

J Rheumatol Suppl. 2015 Nov;93:61-4. doi: 10.3899/jrheum.150639. Review.

PMID:
26523060
40.

The Definition and Measurement of Axial Psoriatic Arthritis.

Lubrano E, Parsons WJ, Marchesoni A, Olivieri I, D'Angelo S, Cauli A, Caso F, Costa L, Scarpa R, Brunese L.

J Rheumatol Suppl. 2015 Nov;93:40-2. doi: 10.3899/jrheum.150634. Review.

PMID:
26523055
41.

Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012.

Piga M, Casula L, Sanna S, Perra D, Floris A, Antonelli A, Cauli A, Mathieu A.

Rheumatol Int. 2016 Jan;36(1):73-81. doi: 10.1007/s00296-015-3330-1. Epub 2015 Jul 26.

PMID:
26211000
42.

Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012.

Piga M, Casula L, Perra D, Sanna S, Floris A, Antonelli A, Cauli A, Mathieu A.

Lupus. 2016 Jan;25(1):28-37. doi: 10.1177/0961203315596597. Epub 2015 Jul 20.

PMID:
26199283
43.

Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report.

Ibba S, Piga M, Congia M, Cauli A, Mathieu A.

Joint Bone Spine. 2016 Jan;83(1):113-4. doi: 10.1016/j.jbspin.2015.03.001. Epub 2015 Jul 14. No abstract available.

PMID:
26184532
44.

Twenty-year brain magnetic resonance imaging follow-up study in Systemic Lupus Erythematosus: Factors associated with accrual of damage and central nervous system involvement.

Piga M, Peltz MT, Montaldo C, Perra D, Sanna G, Cauli A, Mathieu A.

Autoimmun Rev. 2015 Jun;14(6):510-6. doi: 10.1016/j.autrev.2015.01.010. Epub 2015 Jan 21.

PMID:
25617815
45.

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis).

Cauli A, Piga M, Floris A, Mathieu A.

Immunotargets Ther. 2015 Oct 1;4:185-90. doi: 10.2147/ITT.S62870. eCollection 2015. Review.

46.

Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis.

Cauli A, Piga M, Dessole G, Porru G, Floris A, Vacca A, Desogus E, La Nasa G, Mathieu A.

Drug Dev Res. 2014 Nov;75 Suppl 1:S15-9. doi: 10.1002/ddr.21187. Review.

PMID:
25381967
47.

Updated guidelines for the management of axial disease in psoriatic arthritis.

Nash P, Lubrano E, Cauli A, Taylor WJ, Olivieri I, Gladman DD.

J Rheumatol. 2014 Nov;41(11):2286-9. doi: 10.3899/jrheum.140877. Review.

PMID:
25362712
48.

The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis.

Spadaro A, Lubrano E, Marchesoni A, Cauli A, Cantini F, Carotti M, D'Angelo S, Grassi W, Lapadula G, Macchioni P, Mathieu A, Punzi L, Ramonda R, Salaffi F, Salvarani C, Scarpa R, Olivieri I.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4):465-70. Epub 2014 May 21.

PMID:
24850468
49.

Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort.

Piga M, Chessa E, Ibba V, Mura V, Floris A, Cauli A, Mathieu A.

Autoimmun Rev. 2014 Aug;13(8):873-9. doi: 10.1016/j.autrev.2014.05.005. Epub 2014 May 16. Review.

PMID:
24840285
50.

Clinical potential of apremilast in the treatment of psoriatic arthritis.

Cauli A, Porru G, Piga M, Vacca A, Dessole G, Mathieu A.

Immunotargets Ther. 2014 Jun 9;3:91-6. doi: 10.2147/ITT.S40199. eCollection 2014. Review.

Supplemental Content

Support Center